Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Provides Corporate Update and Announces First Quarter 2011 Results May 10, 2011 News Release - Tekmira First Quarter 2011 Results 34.2 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: First Quarter 2011 Operating Results and Corporate Update May 04, 2011 Tekmira Conference Call and Webcast Advisory: First Quarter 2011 Operating Results and Corporate Update 14.5 KB ... Read more Summary ToggleTekmira and the National Cancer Institute Publish Promising Data Demonstrating the Anti-Tumor Activity of a Novel Cancer Target Apr 21, 2011 Tekmira and the National Cancer Institute Publish Promising Data Demonstrating the Anti-Tumor Activity of a Novel Cancer Target 19.4 KB ... Read more Summary ToggleTekmira Announces USPTO Issuance of Key Patents Covering LNP Manufacturing Process and Mitigation of siRNA Immune Stimulation Apr 12, 2011 Tekmira Announces USPTO Issuance of Key Patents Covering LNP Manufacturing Process and Mitigation of siRNA Immune Stimulation 18.3 KB ... Read more Summary ToggleTekmira Comments on Answer and Counterclaim Filed by Alnylam Pharmaceuticals Apr 07, 2011 Tekmira Comments on Answer and Counterclaim Filed by Alnylam Pharmaceuticals 18.9 KB Tekmira's Lawsuit Against Alnylam Outlines Repeated Misuse of Trade Secrets and Confidential Information ... Read more Summary ToggleTekmira and Collaborators Present Data at the American Association for Cancer Research (AACR) Meeting on Tekmira's Lead Oncology Product, TKM-PLK1, and an Oncology Product Candidate Targeting Kinase WEE1 Apr 04, 2011 Tekmira and Collaborators Present Data at the American Association for Cancer Research (AACR) Meeting on Tekmira's Lead Oncology Product, TKM-PLK1, and an Oncology Product Candidate Targeting Kinase WEE1 21.2 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Reports 2010 Audited Results Mar 30, 2011 Tekmira Provides Corporate Update and Reports 2010 Audited Results 33.3 KB Conference Call at 12 noon Eastern Time Today ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Corporate Update and 2010 Audited Results Mar 28, 2011 Tekmira Conference Call and Webcast Advisory: Corporate Update and 2010 Audited Results 14.5 KB ... Read more Summary ToggleTekmira Sues Alnylam Pharmaceuticals for Repeated Misuse of Trade Secrets and Confidential Information Mar 16, 2011 Tekmira Sues Alnylam Pharmaceuticals for Repeated Misuse of Trade Secrets and Confidential Information 23.9 KB ... Read more Summary ToggleTekmira Pharmaceuticals to Present at the ROTH 23rd Annual OC Growth Stock Conference Mar 10, 2011 Tekmira Pharmaceuticals to Present at the ROTH 23rd Annual OC Growth Stock Conference 14.3 KB ... Read more Pagination First page First Previous page Previous … Page 42 Current page 43 Page 44 Page 45 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Provides Corporate Update and Announces First Quarter 2011 Results May 10, 2011 News Release - Tekmira First Quarter 2011 Results 34.2 KB Conference Call at 4:30 pm Eastern Time Today ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: First Quarter 2011 Operating Results and Corporate Update May 04, 2011 Tekmira Conference Call and Webcast Advisory: First Quarter 2011 Operating Results and Corporate Update 14.5 KB ... Read more Summary ToggleTekmira and the National Cancer Institute Publish Promising Data Demonstrating the Anti-Tumor Activity of a Novel Cancer Target Apr 21, 2011 Tekmira and the National Cancer Institute Publish Promising Data Demonstrating the Anti-Tumor Activity of a Novel Cancer Target 19.4 KB ... Read more Summary ToggleTekmira Announces USPTO Issuance of Key Patents Covering LNP Manufacturing Process and Mitigation of siRNA Immune Stimulation Apr 12, 2011 Tekmira Announces USPTO Issuance of Key Patents Covering LNP Manufacturing Process and Mitigation of siRNA Immune Stimulation 18.3 KB ... Read more Summary ToggleTekmira Comments on Answer and Counterclaim Filed by Alnylam Pharmaceuticals Apr 07, 2011 Tekmira Comments on Answer and Counterclaim Filed by Alnylam Pharmaceuticals 18.9 KB Tekmira's Lawsuit Against Alnylam Outlines Repeated Misuse of Trade Secrets and Confidential Information ... Read more Summary ToggleTekmira and Collaborators Present Data at the American Association for Cancer Research (AACR) Meeting on Tekmira's Lead Oncology Product, TKM-PLK1, and an Oncology Product Candidate Targeting Kinase WEE1 Apr 04, 2011 Tekmira and Collaborators Present Data at the American Association for Cancer Research (AACR) Meeting on Tekmira's Lead Oncology Product, TKM-PLK1, and an Oncology Product Candidate Targeting Kinase WEE1 21.2 KB ... Read more Summary ToggleTekmira Provides Corporate Update and Reports 2010 Audited Results Mar 30, 2011 Tekmira Provides Corporate Update and Reports 2010 Audited Results 33.3 KB Conference Call at 12 noon Eastern Time Today ... Read more Summary ToggleTekmira Conference Call and Webcast Advisory: Corporate Update and 2010 Audited Results Mar 28, 2011 Tekmira Conference Call and Webcast Advisory: Corporate Update and 2010 Audited Results 14.5 KB ... Read more Summary ToggleTekmira Sues Alnylam Pharmaceuticals for Repeated Misuse of Trade Secrets and Confidential Information Mar 16, 2011 Tekmira Sues Alnylam Pharmaceuticals for Repeated Misuse of Trade Secrets and Confidential Information 23.9 KB ... Read more Summary ToggleTekmira Pharmaceuticals to Present at the ROTH 23rd Annual OC Growth Stock Conference Mar 10, 2011 Tekmira Pharmaceuticals to Present at the ROTH 23rd Annual OC Growth Stock Conference 14.3 KB ... Read more Pagination First page First Previous page Previous … Page 42 Current page 43 Page 44 Page 45 … Next page Next Last page Last
Tekmira Conference Call and Webcast Advisory: First Quarter 2011 Operating Results and Corporate Update 14.5 KB
Tekmira and the National Cancer Institute Publish Promising Data Demonstrating the Anti-Tumor Activity of a Novel Cancer Target 19.4 KB
Tekmira Announces USPTO Issuance of Key Patents Covering LNP Manufacturing Process and Mitigation of siRNA Immune Stimulation 18.3 KB
Tekmira and Collaborators Present Data at the American Association for Cancer Research (AACR) Meeting on Tekmira's Lead Oncology Product, TKM-PLK1, and an Oncology Product Candidate Targeting Kinase WEE1 21.2 KB
Tekmira Sues Alnylam Pharmaceuticals for Repeated Misuse of Trade Secrets and Confidential Information 23.9 KB
